Abstract:Prostatic carcinosarcoma (PCS) is an extremely rare malignancy and is reported to have a very poor prognosis. A 77-year-old Japanese male was diagnosed as PCS containing two components, adenocarcinoma and leiomyosarcoma by the immunohistochemical analysis. Cytology was initially useful for the diagnosis. Treatments with androgen ablative and surgical therapies could not improve the patient's life, and he died at 12 months after the first visit.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.